Pasithea Therapeutics Stock (NASDAQ: KTTA) stock price, news, charts, stock research, profile.
Open | $5.70 |
Close | $6.02 |
Volume / Avg. | 1.26K / 3.44K |
Day Range | 5.70 - 6.03 |
52 Wk Range | 4.74 - 17.40 |
Market Cap | $6.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 0.76% |
Days to Cover | 2.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pasithea Therapeutics (NASDAQ:KTTA) through any online brokerage.
Other companies in Pasithea Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX), Geovax Labs (NASDAQ:GOVX), NuCana (NASDAQ:NCNA) and Trevena (NASDAQ:TRVN).
There is no analysis for Pasithea Therapeutics.
Pasithea Therapeutics has a consensus price target of $2.00.
The stock price for Pasithea Therapeutics (NASDAQ: KTTA) is $6 last updated July 15, 2024 at 6:45 PM EDT.
There are no upcoming dividends for Pasithea Therapeutics.
Pasithea Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Pasithea Therapeutics.
Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.